CFM
MRK icon

Catalyst Funds Management’s Merck MRK Stock Holding History

Catalyst Funds Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$435K Sell
3,616
-30,384
-89% -$3.51M 0.07% 273
2025
Q4 		$3.58M Buy
34,000
+22,100
+186% +$2.07M 0.83% 19
2025
Q3 		$999K Buy
11,900
+7,100
+148% +$585K 0.15% 143
2025
Q2 		$380K Buy
+4,800
New +$382K 0.11% 240
2024
Q3 		– Sell
-3,100
Closed -$384K – 1491
2024
Q2 		$384K Buy
+3,100
New +$399K 0.1% 132

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Catalyst Funds Management's MRK Position: Q1 2026 in Review

Catalyst Funds Management reduced its Merck (MRK) stake by 89% in Q1 2026, selling an estimated $3.51M and leaving 3,616 shares worth $435K. The position accounts for 0.07% of the portfolio, ranked #273.

Catalyst Funds Management first reported a position in MRK in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.58M in Q4 2025. 3,782 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Catalyst Funds Management held 3,616 shares of Merck worth $435K as of Q1 2026.
  • Catalyst Funds Management sold 30,384 Merck shares in Q1 2026, an estimated $3.51M.
  • Merck made up 0.07% of Catalyst Funds Management's portfolio in Q1 2026, its #273 holding.
  • Catalyst Funds Management first reported a position in Merck in Q2 2024 and has held it in 5 quarters since.
  • Catalyst Funds Management's Merck position peaked at $3.58M in Q4 2025.
  • 3,782 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.